[Use of beta-receptor blockaders in hypertrophic obstructive cardiomyopathy (HOCM)].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006321:Heart / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006984:Hypertrophy; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011433:Propranolol
Die Anwendung von beta-Rezeptorenblockern bei hypertrophischer obstruktiver Kardiomyopathie (HOCM).